Peter J. Hulick MD, MMSc

Dr. Hulick's Harvard genetics training consisted of identifying potential biomarkers of kidney cancer through gene expression profiling of tumor cell lines and the development of a clinical assay to detect kidney cancer at an early stage. He also studied the biological function of the folliculin gene product which, when mutated, causes the kidney cancer predisposition syndrome Birt-Hogg-Dube. During his medical genetics residency, he graduated with a masters in medical science degree from the Harvard Medical Scholars in clinical Science program which trains individuals for careers in clinical research. Current research activities include studies that identify and measure the influences of our genes on health and how to effectively manage these risks. He is also active in leading efforts to incorporate genomic information and testing into NorthShore University HealthSystem.